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Summary
CuII, NiII, CoII, ZnII and CdII complexes of picolin-
amido-4-bis(2-chloroethyl)aminobenzaldimine (PBAB)
have been synthesized and characterized by elemental
analysis, conductivity, i.r. u.v.-vis. and e.p.r. spectra.
The results suggest a square planar structure for the CuII
complex, a tetrahedral geometry for the ZnII and CdII
complexes and an octahedral structure for the CoII and
NiII complexes. The complexes have been screened for
antitumor activity against SMMC-7721 human liver
cancer cell line; all of them exhibit biological activity at
high concentrations for the cell line studied and a
synergic eect between CuII and PBAB is evident.
Introduction
Nitrogen mustards have been used as antitumor agents
and it is well known that this kind of compound can
exert carcinostatic action against transplanted animal
tumors(1). However, lack of selectivity towards tumor
cells and frequent high toxicity have often limited their
use as practical chemotherapeutic agents in the man-
agement of human neoplastic disease(1). Seeking for
higher eect-lower toxicity antitumor agents is an active
research ®eld. Benzaldehyde nitrogen mustard and pi-
colinic acid hydrazide both have signi®cant biological
activity, and their derivatives have been widely investi-
gated(2±3). The antitumor activity of certain transition
metal such as cisplatin is also well known(4±5). However,
reports on metal complexes of nitrogen mustards are
few(6±7). It has been shown(7) that the stability of nitro-
gen mustard in water can be enhanced by coordination
to a metal. This might also allow for the development of
slow release drugs, whilst the synergic eect between
metals and drugs is also worthy of study. Based on this,
we have modi®ed a literature procedure(8±9) to synthe-
size a picolinoyl hydrazone of benzaldehyde nitrogen
mustard. New transition metal complexes of this ligand
have been prepared and investigated for antitumor
activity.
Experimental
All the chemicals used were AR grade reagents. Benz-
aldehyde nitrogen mustard was made by a three-step
synthesis. In the ®rst step, cold ethylene oxide (88 g, 2
mol) was added to a cold solution of freshly distilled
aniline (93 g, 1 mol) and 50 g of 1% aqueous AcOH
solution. The mixture was heated slowly to 70 °C during
2 h and kept at this temperature for 20 h. The white
solid product, N,N-bis(hydroxyethyl)aniline, was iso-
lated under reduced pressure (206±208 °C, 15 mmHg);
yield 162 g, 90%. The next two reactions were carried
out according to references(8±10). Picolinic acid hydra-
zide was made by a two-step synthesis. In the ®rst step,
5 cm3 of concentrated H2SO4 was added slowly to a cold
suspension of picolinic acid (12.3 g, 0.1 mol) in 40 cm3
absolute EtOH, and the mixture was re¯uxed for 26 h.
The cold solution was poured into ice-water and ex-
tracted with Et2O. The white product was obtained by
removing solvent, yield is 7.0 g, 46%. In the second
reaction, N2H4 áH2O (85%, 4 ml, 0.09 mol) was added
to a solution of ethyl picolinate (7 g, 0.046 mol) in EtOH
(40 ml), the mixture was re¯uxed for 2 h and cooled to
room temperature. White needle crystals of picolinic
acid hydrazide were isolated by ®ltration and washed
with EtOH; yield 2.5 g, 40%. The hydrazone (PBAB)
was prepared by the following procedure; a solution of
benzaldehyde nitrogen mustard (2.46 g, 0.01 mol) in
absolute EtOH (30 cm3) was added to a solution of
picolinic acid hydrazide (1.37 g, 0.01 mol) in absolute
EtOH (20 cm3). The mixture was re¯uxed under acid
catalysis (one drop AcOH) for 0.5 h; the yellow pre-
cipitate which formed on cooling the mixture to room
temperature was collected by ®ltration, washed with
absolute EtOH and recrystallized from MeCN; yield
3.1 g, 85%.
Preparation of the complexes
In a typical preparation, a solution of hydrated copper
(II) nitrate (48 mg, 0.2 mmol) in THF (5 cm3) was
added dropwise to a solution of PBAB (146 mg,
0.4 mmol) in THF (10 cm3) with stirring, whereupon a
yellow-green precipitate formed immediately. The mix-
ture was continuously stirred for 8 h to ensure complete
precipitation, then the product was ®ltered o, washed
with THF and dried in vacuo; yield 88 mg, 90%.
MTT assay
SMMC7721 human liver cancer cells were propagated
continuously in culture on Eagles MEM medium sup-
plemented with 10% inactived fetal calf serum (FCS)
and antibiotics. Monolayer cells harvested from expo-
nential phase were treated using trypsin (0.05%) and
then diluted with medium and counted using a hemo-
cytometer, single-cell suspension solutions 1 105=ml
were prepared, and then inoculated into 96 well plates to
a volume of 100 ll/well 1 104 cell/well. The plates
were incubated in a humidi®ed atmosphere of 90%
N2-5% O2-5% CO2 for 24 h, then the compound to
be studied was added in concentration gradient, and
the ®nal concentration was maintained at 125, 100, 75
and 50 lmol á l)1. The plates were incubated at 37 °C
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for 48 h. After the culture medium was removed from
the wells, 100 ll (1 mg/cm3) MTT solution of (3-[4,5-
dimethyl(thiazol-2-yl)-2,5-diphenyl] tetrazolium bro-
mide was added to each well and the plates were incu-
bated for 4 h. The remaining MTT solution was then
removed and 150 ll DMSO was added to each well to
dissolve the formazan crystals(11).
Absorbance readings on each well were measured on
an ELISA spectrophotometer at 570 nm. Blank wells
whose absorbances were zero contained no cells or
medium, but MTT solution was added and removed
after incubation, and 150 ll DMSO was then added.
The control wells were consistent with the experimental
wells except that they did not contain the compounds to
be studied.
The survival ratio (SR) is expressed as A=A0  100%,
where A is average absorbance of the experimental wells
and A0 the average absorbance of the control wells. The
logarithm of concentration of the compounds and SR
were treated by linear regression analysis and ID50 val-
ues were obtained from the equations. ID50 was de®ned
as the drug concentration required to reduce the number
of live cells by 50%.
The elemental analyses were performed on an Ele-
mentar Vario. EL instrument (Elementar Vario. EL,
Germany). I.r. spectra were recorded in the range
4000±200 cm)1 using KBr pellets with a 170SX-FTIR
spectrometer (Nicolet, U.S.A.). 1H n.m.r. spectra were
recorded on an AM-400 instrument (Brucker,
Switzerland) using DMSO-d6 as solvent. Molar con-
ductances of the complexes in DMSO were measured
at room temperature with a DDS-11A type conduc-
tivity bridge (Shanghai analytical instrument factory,
China). E.p.r. spectra were recorded on an ER200-SRC
instrument (Brucker) in the polycrystalline state at
room temperature. Electronic spectra were obtained
with a Shimadzu u.v.-240 spectrophotometer.
Results and discussion
Elemental analyses for free PBAB and its complexes
are presented in Table 1. All of the complexes are
stable in air. They are slightly soluble in ethanol and
acetone, and also easily soluble in DMF and DMSO.
The molar conductivity data in DMSO show that the
copper, cobalt and nickel complexes are non-electro-
lytes, whilst the zinc and cadmium complexes are 1:2
electrolytes(12).
The 1H n.m.r. spectrum of free PBAB shows signals at
11.91 and 8.52 ppm for the NH and CH@N protons
respectively. Signals due to the pyridine ring protons
occur as multiplets between 8.08±8.70 ppm (4H;
J3;4  3:4 Hz; J4;5  5:84 Hz; J5;6  6:28 Hz). The ben-
zene ring protons appear in the range 6.6±7.6 ppm (dd;
4H; J  6:6 Hz) and the signals due to the CH2CH2
protons are at 3.72 and 3.81 ppm. The i.r. absorbances
(Table 2) at 1687 and 1598 cm)1 can be assigned to
m(C@O) and m(C@N) (azomethine), which dier from
the benzaldehyde nitrogen mustard and picolinic acid
hydrazide; in the spectrum of the latter, m(C@O) appears
at 1660±1670 cm)1, hence this is evidence for the for-
mation of a hydrazone(13), with PBAB in mainly the
keto form(14).
I.r. spectra
The i.r. absorbances of free PBAB and its complexes are
presented in Table 2. Free PBAB shows a band assigned
to m(NAH) at 3268 cm)1. For the other complexes apart
from the copper species, this band remains almost un-
changed after complexation, precluding the possibility
of coordination through the imine nitrogen atom(3). The
negative shift of the amide-I Dm  19±54 cmÿ1, posi-
tive shifts of the amide-II Dm  10 cmÿ1 and the
amide-III Dm  6±9 cmÿ1 bands compared to the free
ligand indicate involvement of the carbonyl oxygen at-
om in coordination(15). Ring breathing(15), in-plane
bending and out-of-plane bending(16) vibrations of the
pyridine are shifted to appreciably higher frequencies in
the spectra of the complexes, consistent with coordina-
tion through the ring nitrogen(15). This is further sup-
ported by the presence of a m(MAN) band in the 270±
280 cm)1 region(17).
In the spectrum of the copper(II) complex, the ab-
sence of m(NH), amide-I, amide-II and amide-III bands
and appearance of new bands due to m(N@CAO)
at 1542 and 1387 cm)1(18), indicate enolization and
Table 1. The elemental analytic data and molar conductivities
Compound Found (Calcd. ) %
M C N H
Km
(W1 cm2 mol)1)
PBAB ± 55.9(56.0) 15.3(15.2) 5.0(5.2) ±
[Cu(PBAB-H)NO3] 13.4(13.2) 41.7(41.4) 14.3(14.4) 3.5(3.9) 25
[Cd(PBAB)2](NO3)2 11.6(11.9) 42.2(42.4) 14.5(14.7) 3.8(4.0) 69
[Ni(PBAB)2(NO3)2] 6.4(6.6) 44.7(44.9) 15.3(14.9) 4.0(4.4) 20
[Zn(PBAB)2](NO3)2 7.1(7.1) 44.4(44.1) 15.2(15.4) 3.9(4.2) 64
[Co(PBAB)2(NO3)2] 6.5(6.2) 44.8(44.9) 15.3(15.0) 4.0(4.3) 23












PBAB 1687 1508 1236 1598 966 633 401 ±
Cu(PBAB-H)NO3 ± ± ± 1593 1000 658 410 398/271
Cd(PBAB)2(NO3)2 1658 1518 1241 1594 1014 658 409 393/280
Ni(PBAB)2(NO3)2 1634 1518 1244 1597 1019 647 421 390/273
Zn(PBAB)2(NO3)2 1637 1518 1243 1598 1018 677 416 393/280
Co(PBAB)2(NO3)2 1633 1518 1244 1596 1018 642 413 393/273
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deprotonation of the keto group upon coordination(14).
Positive shifts of m(NAN) (33 cm)1), ring-breathing (44±
53 cm)1), in-plane bending (9±44 cm)1) and out-of-
plane bending (8±20 cm)1) vibrations of the pyridine
ring suggest coordination through the pyridine ring ni-
trogen(19). The m(C@N) (azomethine) band remains un-
aected after complexation, indicating non-involvement
of the azomethine nitrogen atom in coordination. Bands
at 1474, 1030, 810, 1284 and 729 cm)1 can be assigned
to m1±m5 of NO
ÿ
3 ; the combination band m2  m5 appears
at 1760 cm)1, suggesting that the NOÿ3 ions acts as a
bidentate ligand(20) in the copper(II) complex. The uni-
dentate nature of NOÿ3 in the cobalt and nickel com-
plexes is demonstrated by the appearance of i.r. bands at
1474±1475, 1243±1244, 1018±1019, 858±868 and 753±
754 cm)1(21).
E.p.r. spectrum of the copper complex
The e.p.r. spectrum of the polycrystalline copper com-
plex recorded at room temperature shows two peaks
(Figure 1); the weak signal at low ®eld and the strong
one at high ®eld can be assigned to gk and g? respec-
tively. The values of these parameters were calculated as
2.360 and 2.072 respectively. 2B1 is the ground state for
most copper complexes(22) when the unpaired electron is
in a dx2ÿy2 orbital, while
2A1 is the ground state when an
unpaired electron is in a dz2 orbital gk > g? > 2:00. In
the present case, the gk > g?, therefore, the unpaired
electron is likely to be in the dx2ÿy2 orbital. The obser-
vation gk > g? > 2:04 indicates a square planar ge-
ometry around the copper(II) ion. Also observation that
gk > 2:3 is indicative of the ionic nature of the com-
plex(22). The G parameter obtained from the expression
gk ÿ 2=g? ÿ 2 is greater than 4, suggesting that ex-
change interactions between copper(II) centers in the
solid state are negligible. No signal at half ®eld was
observed in the spectrum, ruling out the possibility of a
dimeric form(24).
Electronic spectra
The electronic spectrum of free PBAB in DMSO solu-
tion shows bands at 278 and 333 nm, attributed to
pÿ p transitions of the side chain imine group and to
the pyridine ring in resonance with the C@O group re-
spectively(25). In the complexes, the considerable in-
crease in intensity of the pyridine ring band compared to
free PBAB indicates that the ring nitrogen is involved in
coordination(26). Red shifts (8±10 nm) are observed for
all the complexes. Absorption bands (in nujol) for the
cobalt complex at 520±500 nm and 480±440 nm may be
tentatively assigned to 4T1gF  ! 4A2gm2 and 4T1gF 
! 4T1gP m3 transitions characteristic of octahedral
cobalt(15,22). The electronic spectrum of the nickel
complex shows only a strong broad peak at 440 nm,
which can be assigned to the 3A2g ! 3T1gF  transition.
The m1 band
(25) expected at 943±930 nm would lie out-
side the range of the spectrophotometer, however an
octahedral nickel geometry may be tentatively proposed.
The band at 740±720 nm for the copper complex may be
assigned to the 2B1g ! 2A1g and 2B1g ! 2Eg transitions.
The position of this band indicates a square planar
stereochemistry(27). A high energy band at 480±400 nm
may be assigned to ligand-metal charge transfer.
Based on the above mentioned data, an octahedral
geometry for the cobalt(II) and nickel(II) complexes, a
square planar structure for the copper(II) complex and a
tetrahedral geometry for the zinc(II) and cadmium(II)
complexes can be tentatively proposed (Figure 2).
Antitumor activity
MTT assay is a novel method for quantifying meta-
bolically viable cells through their ability to reduce a
soluble yellow tetrazolium salt to blue-purple formazan
crystals(28). The crystals are thought to be produced by
the mitochondrial enzyme succinate dehydrogenase(29)
and can be quanti®ed by redissolving and measuring the
absorbance of the resultant solution correlating with the
number of live cells. The results of studies of the bio-
logical activities of the complexes are given in Table 3.
The results show that all the complexes have a de®nite
antitumor activity. Although the parent metal nitrates
have some cytotoxicity eect at high concentration, the
eect is not evident at their ID50 dosage (SR > 90%).
The ID50 values of the copper complexes are smaller
than the ID50 of free PBAB, so it is believed that there is
a synergic eect between copper and PBAB, although
Figure 1. E.p.r. spectrum of the copper complex at room temperature.
Figure 2. Proposed structures of the complexes.R=NHN@CHC6H4N
(CH2CH2Cl)2, M  Co or Ni.
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this eect however the situation is not evident in the
other complexes.
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